Edwards, Cook Biotech Collaborate On Permanent Heart Valve Replacement
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences intends to use Cook Biotech's small intestinal submucosa (SIS) technology to create the first permanent replacement heart valve under a worldwide licensing/supply deal
You may also be interested in...
Edwards BioPhysio Valve To Solve Stentless Versus Stented Conundrum
Edwards Lifesciences will begin clinical trials this year for its BioPhysio replacement heart valve technology, combining the advantages of the company's stented and stentless tissue replacement valves
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.